BMXMF
Price
$125.35
Change
-$3.66 (-2.84%)
Updated
Oct 16 closing price
Capitalization
15.15B
Intraday Buy/Sell Signals
SRTOY
Price
$24.20
Change
-$0.39 (-1.59%)
Updated
Oct 17 closing price
Capitalization
23.1B
Intraday Buy/Sell Signals
Interact to see
Advertisement

BMXMF vs SRTOY

Header iconBMXMF vs SRTOY Comparison
Open Charts BMXMF vs SRTOYBanner chart's image
Biomerieux 69 Marcy L'Etoile
Price$125.35
Change-$3.66 (-2.84%)
Volume$15
Capitalization15.15B
Sartorius Stedim Biotech
Price$24.20
Change-$0.39 (-1.59%)
Volume$347
Capitalization23.1B
BMXMF vs SRTOY Comparison Chart in %
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMXMF vs. SRTOY commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMXMF is a Hold and SRTOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (BMXMF: $125.35 vs. SRTOY: $24.20)
Brand notoriety: BMXMF and SRTOY are both not notable
BMXMF represents the Medical Specialties, while SRTOY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BMXMF: 8% vs. SRTOY: 62%
Market capitalization -- BMXMF: $15.15B vs. SRTOY: $23.1B
BMXMF [@Medical Specialties] is valued at $15.15B. SRTOY’s [@Pharmaceuticals: Other] market capitalization is $23.1B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $159.93B to $0. The average market capitalization across the [@Medical Specialties] industry is $11.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMXMF’s FA Score shows that 2 FA rating(s) are green whileSRTOY’s FA Score has 0 green FA rating(s).

  • BMXMF’s FA Score: 2 green, 3 red.
  • SRTOY’s FA Score: 0 green, 5 red.
According to our system of comparison, BMXMF is a better buy in the long-term than SRTOY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMXMF’s TA Score shows that 2 TA indicator(s) are bullish while SRTOY’s TA Score has 6 bullish TA indicator(s).

  • BMXMF’s TA Score: 2 bullish, 3 bearish.
  • SRTOY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SRTOY is a better buy in the short-term than BMXMF.

Price Growth

BMXMF (@Medical Specialties) experienced а -2.84% price change this week, while SRTOY (@Pharmaceuticals: Other) price change was +5.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.25%. For the same industry, the average monthly price growth was +3.05%, and the average quarterly price growth was +51.76%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.29%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +14.72%.

Industries' Descriptions

@Medical Specialties (+0.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.29% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRTOY($23.1B) has a higher market cap than BMXMF($15.2B). SRTOY has higher P/E ratio than BMXMF: SRTOY (76.69) vs BMXMF (33.95). SRTOY YTD gains are higher at: 23.627 vs. BMXMF (18.043). BMXMF has higher annual earnings (EBITDA): 977M vs. SRTOY (740M). SRTOY has more cash in the bank: 745M vs. BMXMF (380M). BMXMF has less debt than SRTOY: BMXMF (506M) vs SRTOY (2.97B). BMXMF has higher revenues than SRTOY: BMXMF (4.12B) vs SRTOY (2.9B).
BMXMFSRTOYBMXMF / SRTOY
Capitalization15.2B23.1B66%
EBITDA977M740M132%
Gain YTD18.04323.62776%
P/E Ratio33.9576.6944%
Revenue4.12B2.9B142%
Total Cash380M745M51%
Total Debt506M2.97B17%
FUNDAMENTALS RATINGS
BMXMF: Fundamental Ratings
BMXMF
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
78
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMXMFSRTOY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 4 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 1 day ago
30%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
29%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHH21.580.16
+0.75%
Schwab US REIT ETF™
FLCC31.540.14
+0.46%
Federated Hermes MDT Large Cap Core ETF
TOLZ54.070.17
+0.31%
ProShares DJ Brookfield Global Infras
FYC92.99-0.76
-0.81%
First Trust Small Cap Gr AlphaDEX® ETF
NVDQ0.94-0.01
-1.01%
T-REX 2X Inverse NVIDIA Daily Target ETF

BMXMF and

Correlation & Price change

A.I.dvisor tells us that BMXMF and SOAGY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMXMF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMXMF
1D Price
Change %
BMXMF100%
N/A
SOAGY - BMXMF
26%
Poorly correlated
+1.69%
FONR - BMXMF
24%
Poorly correlated
-0.83%
SRTOY - BMXMF
23%
Poorly correlated
-1.57%
SNN - BMXMF
22%
Poorly correlated
+1.48%
BIO - BMXMF
21%
Poorly correlated
-0.76%
More

SRTOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTOY has been loosely correlated with SOAGY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTOY jumps, then SOAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTOY
1D Price
Change %
SRTOY100%
-1.57%
SOAGY - SRTOY
48%
Loosely correlated
+1.69%
SDMHF - SRTOY
35%
Loosely correlated
N/A
SARTF - SRTOY
24%
Poorly correlated
N/A
BMXMF - SRTOY
24%
Poorly correlated
N/A
CHEOY - SRTOY
23%
Poorly correlated
+0.63%
More